Technical Analysis for MTCR - Metacrine, Inc.

Grade Last Price % Change Price Change
F 9.51 5.67% 0.51
MTCR closed up 5.67 percent on Tuesday, January 19, 2021, on 1.38 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Up Up
Historical MTCR trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Weak + Overbought Other 0.00%
Above Upper BB Strength 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
50 DMA Support Bullish 5.67%
MACD Bullish Centerline Cross Bullish 5.67%
Stochastic Reached Overbought Strength 5.67%
Weak + Overbought Other 5.67%
Older End-of-Day Signals for MTCR ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Upper Bollinger Band Resistance about 11 hours ago
2x Volume Pace about 15 hours ago
Gapped Up (Full) about 16 hours ago
Rose Above Previous Day's High about 16 hours ago
Rose Above Upper Bollinger Band about 16 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Metacrine is a clinical-stage biopharmaceutical company building a differentiated pipeline of therapies to treat liver and gastrointestinal (GI) diseases. The company’s most advanced programs, MET409 and MET642, target the farnesoid X receptor (FXR), which is central to modulating liver and GI diseases. Both MET409 and MET642 are currently being investigated in clinical trials as potential new treatments for non-alcoholic steatohepatitis (NASH).
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Life Sciences Diseases Alcohol Chemical Compounds Gastrointestinal Specialty Drugs Steatohepatitis Hepatitis Gastrointestinal Disease Non Alcoholic Fatty Liver Disease Carboxylic Acids Farnesoid X Receptor Fxr Gi Disease

Is MTCR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 16.19
52 Week Low 7.64
Average Volume 67,205
200-Day Moving Average 0.00
50-Day Moving Average 8.80
20-Day Moving Average 8.44
10-Day Moving Average 8.73
Average True Range 0.53
ADX 19.38
+DI 31.59
-DI 14.96
Chandelier Exit (Long, 3 ATRs ) 8.91
Chandelier Exit (Short, 3 ATRs ) 9.33
Upper Bollinger Band 9.32
Lower Bollinger Band 7.56
Percent B (%b) 1.11
BandWidth 20.80
MACD Line 0.07
MACD Signal Line -0.07
MACD Histogram 0.1388
Fundamentals Value
Market Cap 246.84 Million
Num Shares 26 Million
EPS
Price-to-Sales 0.00
Price-to-Book 2.11
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.19
Resistance 3 (R3) 10.19 9.97 10.07
Resistance 2 (R2) 9.97 9.80 9.97 10.03
Resistance 1 (R1) 9.74 9.69 9.63 9.74 10.00
Pivot Point 9.52 9.52 9.47 9.52 9.52
Support 1 (S1) 9.29 9.35 9.18 9.29 9.02
Support 2 (S2) 9.07 9.24 9.07 8.99
Support 3 (S3) 8.84 9.07 8.95
Support 4 (S4) 8.84